HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities

Nilavar, NM and Raghavan, SC (2021) HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities. In: International Immunopharmacology, 95 .

PDF int_imm_95_2021.pdf - Published Version Restricted to Registered users only Download (3MB) | Request a copy

Abstract

Multiple steps of the retroviral infection process have been targeted over the years to develop therapeutic approaches, starting from the entry of the virus into the cell till the viral DNA integration to host genome. Inhibitors against the Human Immunodeficiency Virus (HIV) integrase is the newest among the therapies employed against HIV. Recombination activating gene 1 (RAG1) is an integral protein involved in the generation of diversity of antibodies and T-cell receptors and is one of the partners of the RAG complex. Studies have shown structural and functional similarities between the HIV integrase and RAG1. Recently, we and others have shown that some of the integrase inhibitors can interfere with RAG binding and cleavage, hindering its physiological functions. This mini review focuses on the HIV integrase, integrase inhibitors and their effect on RAG activities. © 2021 Elsevier B.V.

Item Type:	Journal Article
Publication:	International Immunopharmacology
Publisher:	Elsevier B.V.
Additional Information:	The copyright for this article belongs to Elsevier B.V.
Department/Centre:	Division of Biological Sciences > Biochemistry
Date Deposited:	30 Mar 2021 06:20
Last Modified:	30 Mar 2021 06:20
URI:	http://eprints.iisc.ac.in/id/eprint/68576

Actions (login required)

View Item